Source: CNW GROUP LTD

Press Release: Encycle Therapeutics : Encycle Therapeutics working with major pharmaceutical companies to design rules for drugs meant to be swallowed

CQDM and MaRS Innovation investing in new Encycle project to determine rules for making peptide drugs orally bioavailable PHILADELPHIA, June 16, 2015 /CNW/ - FiercePharma has predicted that the pharmaceutical industry stands to lose $44 billion in drugs going off patent in 2015....

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Jeffrey A.M. Coull's photo - President & CEO of Encycle Therapeutics

President & CEO

Jeffrey A.M. Coull

CEO Approval Rating

82/100

Read more